Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Galdieria Co. Ltd. currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 actions are being handled by 2 distinct examiners, ensuring that each matter receives an independent review. Furthermore, the applications are situated in 2 distinct art units, suggesting that the company's intellectual property covers different biotechnological specialties within the broader technology area.
VAN BUREN, LAUREN K is the busiest examiner with 1 pending action. Because there are only 2 pending actions in total, this single action represents a significant portion of the current prosecution activity. The distribution across 2 distinct art units and 2 distinct examiners means that Galdieria Co. Ltd. is not currently facing any concentration of examiner risk or art unit specific delays.
With 2 pending office actions and 2 distinct examiners, the company must address two separate sets of examiner expectations. The 2 distinct art units involved indicate that the technical subject matter is sufficiently different to be classified into separate examination categories. This focused but divided portfolio requires precise attention to the specific requirements of each individual examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VAN BUREN, LAUREN K | 1 | 40.0% | +58.4% |
| PULLEN, NIKOLAS TAKUYA | 1 | 52.5% | +8.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18240059 | Metal Recovery Agent, Metal Compound Recovery Agent, and Method for Recovering Metal or Metal Compound | PULLEN, NIKOLAS TAKUYA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19350359 | AGENT FOR SELECTIVE METAL RECOVERY, METAL RECOVERY METHOD, AND METAL ELUTION METHOD | VAN BUREN, LAUREN K | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 1733 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19350359 | AGENT FOR SELECTIVE METAL RECOVERY, METAL RECOVERY METHOD, AND METAL ELUTION METHOD | VAN BUREN, LAUREN K | 1638 | §102§103DP | Final Rejection | — | Pending | Oct 06, 2025 |
| 18240059 | Metal Recovery Agent, Metal Compound Recovery Agent, and Method for Recovering Metal or Metal Compound | PULLEN, NIKOLAS TAKUYA | 1733 | §103§112 | Final Rejection | — | Pending | Aug 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGaldieria Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Lauren K Van Buren has the most, with 1 of Galdieria Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
